Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Neglected Tropical Diseases (NTDs) movement
3. The “chronic pandemic” that just won’t go away (1)
4. The “chronic pandemic” that just won’t go away (2)
5. NTDs - common features
6. NTDs shackle the world’s poorest in poverty
7. The ‘brand identity’ of NTDs
8. On the road to overcome the impact of NTDs
9. Resolution WHA 66.12
10. The impact of NTDs on additional issues
11. Global burden of disease 2010
12. Donated quality-assured essential medicines
13. Global Alliance for Eliminating Lymphatic Filariasis
14. NTDs – an agenda for 2030
15. NTDs are part of the target for improved health
16. SDGs and NTDs (1)
17. SDGs and NTDs (2)
18. NTDs and the Health system
19. Inefficiency and waste in the supply of drugs
20. Poor-quality antimalarial drugs
21. High level of NTDs drugs consumed by communty
22. Comorbidity between mental health and NTDs
23. Front cover of the Lancet January 2nd 2010
24. Range of treatment costs per person per year
25. Cost effectiveness of NTDs
26. 2010 average of AFR low income countries
27. NTDs and innovation
28. Health education game for school children
29. Guinea worm, Dracunculiasis
30. Simple intervention to prevent Guinea worm
31. Guinea Worm disease
32. Stamps for advocacy of Guinea worm programme
33. Declines in annual number of Dracunculiasis cases
34. Wajin, Burkina Faso, 1974
35. Samandeni, Burkina Faso 1975
36. River blindness programmes
37. Achievements of OCP and APOC
38. Disease elimination as a public health problem
39. The rationale for policy and priority (1)
40. The rationale for policy and priority (2)
41. The six E's
42. Aedes aegypti – the ancient threat
43. Some challenges to the progress (1)
44. Some challenges to the progress (2)
45. The urban challenge
46. Socio-economical impact of NTDs
47. End game challenges in preventive chemotherapy
48. Challenges: Science to policy and practice
49. NTDs are markers and drivers of poverty
50. Disabled by the belief that only 3 diseases matter
51. Blind to opportunity and achievement
52. NTDs are low hanging fruit
53. Acknowledgements

Topics Covered

• Neglected Tropical Diseases (NTDs)
• Global burden of NTDs
• NTDs and the health system
• NTDs and innovation
• The socio-economical impact of NTDs
• Role and importance of effective partnerships and alliances
• Cost effectiveness of interventions and innovations
• Examples of recent achievements and successes
• Current challenges in NTD management

Links

Series:

• Neglected Tropical Diseases

Categories:

• Clinical Practice

Therapeutic Areas:

• Infectious Diseases

Talk Citation

Publication History

• Published on May 30, 2019

Financial Disclosures

• Professor Molyneux’s research has been supported by the UK Department for International Development, the World Health Organization, the Bill and Melinda Gates Foundation, GlaxoSmithKline, Sanofi, and Sightsavers International who have provided support for work on Neglected Tropical Disease at the Liverpool School of Tropical Medicine. He also receives Honoraria from The Royal Society of Tropical Medicine and Hygiene, and Sightsavers.